Prothena | PRTA - Ebitda





Ebitda Изменить Дата
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Akebia Therapeutics USD 14.03M 17.19M 2025-03
ALKERMES USD 120.06M 19.15M 2026-09
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Exelixis USD 275.36M 19.96M 2026-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
MacroGenics USD -64.54M 34.34M 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Prothena USD -18.49M 44.46M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06